ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
14 août 2024 08h00 HE
|
ProPhase Labs, Inc.
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun in Q3 2024 and Potential Sale of Business ...
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
09 mai 2024 08h00 HE
|
ProPhase Labs, Inc.
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics...
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
04 janv. 2024 08h00 HE
|
ProPhase Labs, Inc.
Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time industry veteran Jed Latkin as COO to help build and manage this growth Garden...
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021
12 nov. 2021 08h30 HE
|
ProPhase Labs, Inc.
Company to hold a conference call November 12, 2021 at 11:00AM ET Garden City, NY, Nov. 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics...
ProPhase Labs Announces $6 Million Stock Repurchase Program
08 sept. 2021 08h30 HE
|
ProPhase Labs, Inc.
Garden City, NY, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announced that its Board of Directors has authorized the...
ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
11 août 2021 08h30 HE
|
ProPhase Labs, Inc.
Nebula Founder and Renowned Harvard Scientist, George Church, Ph.D., to Spearhead ProPhase Labs New Scientific Advisory Board GARDEN CITY, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc....